Breakthrough mRNA Vaccine Offers New Hope Against Pancreatic Cancer Recurrence
A groundbreaking mRNA vaccine demonstrated remarkable potential in preventing pancreatic cancer recurrence, with some patients remaining cancer-free for over 3 years in a small clinical trial, offering new hope by training the immune system to recognize and attack cancer cells.